Archive for the ‘Gene Therapy Research’ Category

Genetics ultimately determines what kind of person are
Genetics ultimately determines what kind of person are changes in communication skills Adaption is evolution truth as soon as it is known "associated memory" physiological vlog voice s daily logical personal thinking individual Psychology examination thinker reasoning ability subjective perspective living interest analyze routine Rationalism show skepticism and criticism voicecast singing songs speak talking discussion of debade evaluation talkin about random stuff speaking music Singer relax philosophy physics cantanteFrom:duffbunchaViews:0 0ratingsTime:05:24:29More inPeople Blogs

Link:
Genetics ultimately determines what kind of person are - Video

LB Genetics - DNA Testing
DNA Paternity and Family Relationship Testing. Trusted by the Kardashians and the Courts!From:DrJohnTaddieViews:0 0ratingsTime:01:16More inScience Technology

Follow this link:
LB Genetics - DNA Testing - Video

Human Genetics: Parody of Beauty and a Beat
A Biology Project we had to do 🙂 For: Mr.Moore who likes to run over bunnys.From:Neonnerd12Views:0 0ratingsTime:04:41More inFilm Animation

Original post:
Human Genetics: Parody of Beauty and a Beat - Video

CSASmartGroup - Genetics Made Easy for MRCGP CSA Exam.
Visit csasmartgroup.com to get all the materials you need to pass your CSA easily! Get your FREE CSA Video Training Series and CSA E- Book.From:CSASmartGroupViews:0 0ratingsTime:00:09More inEducation

Read the rest here:
CSASmartGroup - Genetics Made Easy for MRCGP CSA Exam. - Video

Turing #39;s Cathedral: Author George Dyson in Conversation with John Hollar
Legendary historian George Dyson vividly re-creates the scenes of focused experimentation, incredible mathematical insight, and pure creative genius that gave us computers, digital television, modern genetics, models of stellar evolution mdash;in other words, computer code. In the 1940s and #39;50s, a group of eccentric geniuses mdash;led by John von Neumann mdash;gathered at the newly created Institute for Advanced Study in Princeton, New Jersey. Their joint project was the realization of the theoretical universal machine, an idea that had been put forth by mathematician Alan Turing. This group of brilliant engineers worked in isolation, almost entirely independent from industry and the traditional academic community. But because they relied exclusively on government funding, the government wanted its share of the results: the computer that they built also led directly to the hydrogen bomb. George Dyson has uncovered a wealth of new material about this project, and in bringing the story of these men and women and their ideas to life, he shows how the crucial advancements that dominated twentieth-century technology emerged from one computer in one laboratory, where the digital universe as we know it was born. Join John Hollar for a captivating conversation with Dyson about John von Neumann and the beginnings of the digital universe.From:ComputerHistoryViews:0 0ratingsTime:53:10More inScience Technology

Read this article:
Turing's Cathedral: Author George Dyson in Conversation with John Hollar - Video

A gene inserted into ordinary heart cells transformed them into rare "pacemaker" cells that regulate cardiac rhythm, according to experiments carried out on lab rodents.

The research is a step toward the goal of a biological fix for irregular heartbeat, which at present is tackled by drugs or electronic pacemakers, its investigators said.

The heart has 10 billion cells but fewer than 10,000 are pacemaker cells, which generate electrical activity that spreads to other cardiac cells, making the organ contract rhythmically and pump blood.

The work, reported in the journal Nature Biotechnology, uses a virus to deliver a human gene called Tbx18, whose normal role is to coax immature cells into becoming pacemaker cells.

Ordinary cells "infected" by the harmless Trojan horse were reprogrammed by Tbx 18 and became these important specialised cells.

"The new cells generated electrical impulses spontaneously and were indistinguishable from native pacemaker cells," said Hee Cheol Cho at the Cedars-Sinai Heart Institute in Los Angeles, California.

The promising technique builds on decade-long research into biological pacemakers. So it has so far been tested on guinea pigs and rats.

Read more from the original source:
Gene turns cells into 'pacemaker'

A gene inserted into ordinary heart cells transformed them into rare "pacemaker" cells that regulate cardiac rhythm, according to experiments carried out on lab rodents.

The research is a step toward the goal of a biological fix for irregular heartbeat, which at present is tackled by drugs or electronic pacemakers, its investigators said.

The heart has 10 billion cells but fewer than 10,000 of them are pacemaker cells, which generate electrical activity that spreads to other cardiac cells, making the organ contract rhythmically and pump blood.

The work, reported in the journal Nature Biotechology on Sunday, uses a virus to deliver a human gene called Tbx18, whose normal role is to coax immature cells into becoming pacemaker cells.

Ordinary cells "infected" by the harmless Trojan horse were reprogrammed by Tbx 18 and became these important specialised cells.

"The new cells generated electrical impulses spontaneously and were indistinguishable from native pacemaker cells," said Hee Cheol Cho at the Cedars-Sinai Heart Institute in Los Angeles, California.

The promising technique builds on decade-long research into biological pacemakers. So it has so far been tested on guinea pigs and rats.

"We expect this to work in humans. It would be two to three years from now until the first clinical trial, the first target patients being the ones with (pacemaker) device infection," Cho said in an email to AFP.

Here is the original post:
Gene turns heart cells into pacemaker: lab study

A mutation in a certain gene linked to an increased risk of breast and ovarian cancer could help with prevention measures, research has found.

A team of researchers led by the Institute of Cancer Research (ICR) found that mutations in a gene called PPM1D is linked to an increased risk of the two cancers.

Women with PPM1D mutations have a 20% chance of developing breast or ovarian cancer - double the breast cancer risk and more than 10 times the ovarian cancer risk of women in the general population. But the discovery could help with genetic testing and prevention in particular for ovarian cancer, which is often diagnosed at an advanced stage.

The study, published in the journal Nature this week, said that PPM1D seems to be working in a completely different way to other genes known to increase the risk of breast and ovarian cancer, such as BRCA1 and BRCA2.

Study leader Professor Nazneen Rahman, head of genetics at the ICR and head of the cancer genetics clinical unit at The Royal Marsden NHS Foundation Trust, said: "This is one of our most interesting and exciting discoveries.

"At every stage the results were different from the accepted theories. We don't yet know exactly how PPM1D mutations are linked to breast and ovarian cancer, but this finding is stimulating radical new thoughts about the way genes and cancer can be related.

"The results could also be useful in the clinic, particularly for ovarian cancer which is often diagnosed at an advanced stage. If a woman knew she carried a PPM1D mutation and had a one in five chance of developing ovarian cancer, she might consider keyhole surgery to remove her ovaries after completing her family."

The team analysed 507 genes involved in DNA repair in 1,150 women with breast or ovarian cancer, identifying PPM1D gene mutations in five women. They then sequenced the PPM1D gene in 7,781 women with breast or ovarian cancer and 5,861 people from the general population. There were 25 faults in the PPM1D gene in women with cancer and only one in the general population, a highly statistically significant difference.

Professor Alan Ashworth, ICR chief executive and one of the study researchers, said: "This discovery really does turn conventional wisdom about the way genetic mutations can lead to cancer on its head. "As we unravel this puzzle, we are likely to gain valuable insights about how cancer develops, and new tools for assessing people's risk of the disease and targeting preventive treatment."

The study was funded by the ICR, the Wellcome Trust, Cancer Research UK and Breakthrough Breast Cancer.

Continue reading here:
Mutation in gene could fight cancer

Genetic Engineering Infomercial.m4v
From:Shaista DhanesarViews:0 0ratingsTime:12:23More inPeople Blogs

View original post here:
Genetic Engineering Infomercial.m4v - Video

The Scoop on Genetic Engineering
A bacteria (E-Coli) and or a virus is used to invade the cell of a species or organism by inserting (forcing) a gene from another incompatible species or organism with a desired trait. Genetically Modified Organisms are linked to disorders such as pre-mature aging, allergies, inflammatory bowel disease, infertility, autism, cancer and more. The natural way of creating a hybrid plant is by crossing and re-crossing plants of compatible species for desired traits. For more information and videos http://www.babyboomerfitnessusa.comFrom:Paul GiomiViews:1 0ratingsTime:02:29More inNonprofits Activism

Originally posted here:
The Scoop on Genetic Engineering - Video

SHERWOOD, Ore., Dec. 17, 2012 /PRNewswire/ -- Entia Biosciences (ERGO), a food science biotechnology company and emerging leader in the fields of Nutrigenomics and Targeted Nutrition, has received a Patent Notice of Allowance from the Canadian Intellectual Property Office covering the use of Ergothioneine and its genetic transporter (SLC22A4) in the treatment of a wide variety of diseases, including those affecting the immune and central nervous systems. Ergothioneine is a powerful amino acid and master antioxidant that is acquired exclusively from the diet and carried by this unique and specific transporter to cells throughout the body that are fighting damage and death from oxidative stress and toxic free radical reactions. Research conducted by Entia since 2011 has confirmed significant transporter activity in diabetes, arthritis, and several other serious non-communicable chronic conditions, suggesting an important physiologic role for Ergothioneine in diseases affecting millions of people world-wide.

"We are very pleased that our intellectual property estate on Ergothioneine is advancing nicely alongside the scientific, clinical and other business developments at Entia," said Marvin S. Hausman MD, Chairman and Chief Executive Officer. "The issuance of this important foundational patent significantly enhances the commercialization strategy for our ErgoD2 line of proprietary medical foods, functional ingredients, and other nutritional supplementation solutions in 2013 and for the potential development of a commercial diagnostic test that could one day identify specific dietary deficiencies."

Found in naturally high concentrations almost exclusively in mushrooms and other fungi, Ergothioneine is transferred directly from these sources into the soil, where it is taken up by plants and grazing mammals. For thousands of years, our hunter/gatherer genetics have relied on this process to maintain adequate levels of Ergothioneine to prevent or delay the onset and progression of disease. Entia theorizes introduction of modern agricultural practices in the past century, such as the heavy use of chemical fertilizers, insecticides, and over tilling of the soil, has been gradually eradicating mushrooms from our farmland and depleting Ergothioneine from the food supply. During this same period, our dietary habits have been changing, which Entia believes is further accelerating deficiency in the general population and may explain the dramatic increases we are now seeing in diabetes, arthritis, neurodegenerative, and other debilitating diseases. This deficiency theory is supported by human blood testing conducted in the late 1920s1 that showed "normal" Ergo levels nearly double those found by Pennsylvania State University in 20102.

Discovered in 2005 by Dr. Dirk Grundemann at the University of Cologne (Germany), SLC22A4 is a sodium-ion dependent transporter that efficiently and specifically carries Ergothioneine across the cell membrane to erythrocytes (red blood cells), progenitor stem cells, and monocytes (white blood cells) (Grundemann, 2005). Variations in SLC22A4 have been associated with susceptibility to inflammatory disorders, such as rheumatoid arthritis and Crohn's disease, and expression has been documented in a variety of human tissues. Entia licensed the exclusive world-wide diagnostic and therapeutic rights to the discovery from the University of Cologne in 2010 and Dr. Grundemann currently serves on Entia's Scientific Advisory Board.

Dr. Solomon Snyder of Johns Hopkins University School of Medicine has suggested that Ergothioneine is as potent as glutathione and because of its dietary origin and the toxicity associated with its depletion, it may represent a new vitamin whose physiologic roles include antioxidant cytoprotection. Dr. Snyder further believes that the high density of Ergothioneine within mitochondria implies a unique role in protecting mitochondrial DNA from damage induced by free radicals and reactive oxygen species (Snyder, 2009). Mitochondria are cytoplasmic organelles responsible for life and death. Evidence from animal and clinical studies suggest that mitochondria play a critical role in aging, cancer, diabetes and neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease (Simon, 2004; Lin, 2006; Reddy, P.H., 2009). Further supportive evidence of the potential protective role of Ergothioneine was recently shown by the presence of elevated levels in the red blood cells of pregnant women with the condition preeclampsia. There is currently no known cause for this condition, which affects nearly 10% of pregnancies reaching 20 weeks. The symptoms of preeclampsia include high blood pressure, protein in urine, and fluid retention and left untreated the condition can cause a range of problems such as growth restriction in babies and even fetal and maternal mortality. Ergothioneine is known as an antioxidant and antioxidants have been proposed to be helpful in reducing the risk of preeclampsia. It is therefore very interesting that we have found it to be in excess for women with the condition (Turner, E., 2009)."

About Entia Biosciences, Inc.

Entia is an authority on the clinical effects of oxidative stress and free radical reactions and is bringing this expertise to the fields of food science biotechnology and nutrigenomics. The Company identifies, scientifically validates, patents, and commercializes solutions that address multi-billion dollar markets for health, beauty and agriculture.

For more information, please visit our web sites at http://www.entiabio.com or contact:

Devin Andres Vice President Entia Biosciences, Inc. 13565 SW Tualatin-Sherwood Rd Sherwood, OR, 97140 Phone: 503-334-3575 Email: info@entiabio.com

Any statements contained in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties including, but not limited to, the risks associated with the transaction described in this press release, and other risks identified in the filings by Entia Biosciences with the Securities and Exchange Commission. Further information on risks faced by the Company and its shareholders are detailed in the Form 10-K for the year ended December 31, 2011 and in its subsequent Quarterly Reports on Form 10-Q. These filings are or will become available on a website maintained by the Securities and Exchange Commission at http://www.sec.gov. The information contained in this press release is accurate as of the date indicated. Actual results, events or performance may differ materially. Entia does not undertake any obligation to publicly release the result of any revision to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Read more here:
Entia Receives Canadian Patent Notice of Allowance for Use of Ergothioneine and its Genetic Transporter

NEW YORK, Dec. 17, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

North America In Vitro Diagnostics Market Outlook to 2018- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture http://www.reportlinker.com/p0763031/North-America-In-Vitro-Diagnostics-Market-Outlook-to-2018--Clinical-Chemistry-Genetic-Testing-Haematology-Histology-and-Cytology-Immuno-Chemistry-Infectious-Immunology-and-Microbiology-Culture.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

North America In Vitro Diagnostics Market Outlook to 2018- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Summary

GlobalData's new report, "North America In Vitro Diagnostics Market Outlook to 2018- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture" provides key market data on the North America In Vitro Diagnostics market Canada and United States. The report provides value (USD million) data for all the market categories Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Countries covered include Canada and United States. - Market size and company share data for In Vitro Diagnostics market categories Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture. - Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2004 to 2011, forecast forward for 7 years to 2018. - 2011 company shares and distribution shares data for each of the market categories and countries. - Global corporate-level profiles of key companies operating within the North America In Vitro Diagnostics market.. - Key players covered include Siemens Healthcare, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Beckman Coulter, Inc., Ortho-Clinical Diagnostics Inc., Alere Inc. and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the North America In Vitro Diagnostics competitive landscape. - Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what's the most preferred mode of product distribution Identify, understand and capitalize.

The rest is here:
North America In Vitro Diagnostics Market Outlook to 2018- Clinical Chemistry Genetic Testing, Haematology, Histology ...

NORTH KINGSTOWN, R.I., Dec. 17, 2012 /PRNewswire/ --Dominion Diagnostics has entered into an exclusive agreement with LifeGen, Inc. for the licensing rights to patented genetic testing. Currently the two companies are involved in a research study aimed at validating the testing against the Addiction Severity Index (ASI) designed and marketed by Inflexxion, Inc. The research results are on track to be released in the first quarter of 2013, and are expected to show that LifeGen's test is valuable in determining a patient's Genetic Addiction Risk Score (GARS), or relative predisposition in manifesting addictive behaviors. Approximately 400 patient subjects selected from addiction treatment facilities across the country are involved in the GARS analysis.

The GARS analysis is set to investigate a panel of genes primarily involved in brain reward circuitry. For 30% of the human population (approximately 100 million people), genetics are a large factor in dopamine-driven addiction. This subset of the population carries the DRD2 Type A1 receptor gene which induces low dopamine brain function that results in the propensity for addictive cravings. The GARS test involves a number of reward genes and related polymorphisms which have significant impact on substance use disorders.

LifeGen's Kenneth Blum, PhD is the primary investigator on the companies' current research. Blum is credited with the first known association of the dopamine D2 receptor (DRD2) gene with alcoholism and other addictive behaviors including drug addiction, smoking, overeating, gambling, and sex (Blum & Noble, JAMA, 1990).

"I am confident that the results from our mutual research will provide clinical evidence associating the GARS test with the Addiction Severity Index (ASI)," Dr. Blum said. "The GARS analysis will ultimately be an important front line 'window' into the brain of millions enabling the clinician with genetic information and taking out the guess work to identify those at risk for all addictive behaviors."

In the last decade, genetic variants in the Cytochrome P450 (CYP450) system have been identified and pharmacogenetic testing has been developed that can distinguish differences in a patient's ability tometabolize drugs.Although most insurers do not currently cover the cost of testing, Dominion has determined that there isa critical need to classify patients at genetic risk for drug seeking behavior or addiction prior to treatment. The risk severity associated with a predisposition to addiction, due to polymorphisms in the DRD2 gene rather than genes in the CYP450 system may have greater clinical relevance to today's epidemic level of drug abuse and misuse.

Dominion Diagnostics and LifeGen, Inc. are confident that their GARS analysis results will provide valuable information in a multitude of medical specialties, including but not limited to addiction treatment, pain management, primary care, family medicine, and adolescent treatment.

About Dominion Diagnostics

Dominion Diagnostics is a leading national monitoring company that offers comprehensive medication and substance use monitoring services and a full suite of clinical support solutions. Since 1997, Dominion Diagnostics has provided services to thousands of clients representing a diversity of medical specialties across the United States, including addiction medicine, behavioral health, pain medicine, primary care, psychiatry, and hospital systems. Dominion Diagnostics is supported by a world-class team that shares a commitment to clinical excellence, compliance, and integrity. For more information, please visit http://www.dominiondiagnostics.com.

About LifeGen, Inc.

LifeGen, Inc. (LG) is a vertically integrated nutrigenomic technology company with offices in the suburbs of Philadelphia Pennsylvania, Austin Texas, and San Diego California. LG is the first "nutrition gene therapy" company utilizing "polygenic targeting" as a platform technology for personalized medicine. LG is the only known company holding patents from the USA and Europe that couples DNA testing with a customized nutrigenomic solution. LG is the pioneer, leader, and gold standard of DNA-directed precision nutrition, especially in the realm of neuroendocrine science. With over 100 years of team research experience conducted on the genetic and nutritional causes of many common healthcare concerns, LG provides non-prescription nutrigenomic health solutions to people based on DNA targets that optimize gene expression. For more information, please visit http://www.rewarddeficiencysyndrome.com.

Read more here:
Exclusive Agreement for Genetic Testing and Research Announced Between Dominion Diagnostics and LifeGen, Inc.

Effects of Steroids on the Body
Genetics Project for Ms. Amanda WagnerFrom:Sam DiCaroViews:0 0ratingsTime:02:44More inScience Technology

More here:
Effects of Steroids on the Body - Video

Mission Control - Genetics
Mission Control live at Cloud 9 12/15/12!!!!! http://www.facebook.comFrom:RaisingtheGutterViews:3 0ratingsTime:04:00More inMusic

Read more:
Mission Control - Genetics - Video

IUFO Congress 2010 Melinda Leslie Niara Isley - The Reality of Government Sponsored Covert-ops 8/8
Melinda Leslie Niara Isley Presents The Reality of Government Sponsored Covert - Ops Abduction Experiences Melinda Leslie will discuss how the covert-ops #39; reverse-engineering of extraterrestrial abductees is redefining both the UFO cover-up and abduction paradigms by showing that the management of ET related information and technology includes the monitoring and re-abduction of alien abductees. She explains that just as covert-ops personnel gathers and reverse-engineers ET craft, they also gather and reverse-engineer abductees - and for the same reason - furthering development of secret technology programs and control of ET information. She #39;ll explain that military person:X-XML: nel surveillance, re-abduct and interrogate abductees to gather information on the ET #39;s motives, ET genetics, abductee psi (paranormal) abilities and ET technology. Melinda will share startling new developments, the evidence, and experiences from her research and how this covert-ops #39; involvement may be the best evidence for the reality and importance of UFO abduction. Additionally, Melinda #39;s presentation demonstrates why there can #39;t be an official disclosure without it addressing the abduction phenomenon. Following her will be Niara, a powerful first-hand example of many of the latest developments. FAIR USE NOTICE:Any copyrighted material is for the sole purpose of educatoin and NO profit in any way is being obtainedFrom:speedsterDyViews:2 0ratingsTime:15:11More inScience Technology

The rest is here:
IUFO Congress 2010 Melinda Leslie

Superhero Genetics!
Allan MaxFrom:aht0123Views:1 0ratingsTime:06:26More inPeople Blogs

See more here:
Superhero Genetics! - Video

Molecular Cytogenetics, Superdomestication, Biodiversity and Crop Breeding
Please #39;Like #39; and follow at http://www.molcyt.org Climate Proofing of Food Crops, through genetic improvement for adaptation, is an important, medium-term, objective to ensure food-security and increase production while enhancing the sustainability of agriculture. In the video here, I discuss some of the challenges plant researchers are addressing, and review some of the collaborative work of our Molecular Cytogenetics group that relates to understanding crop evolution, measuring biodiversity, and exploiting and quantifying genetic diversity by hybridization, mapping, introgression, and cell fusion. A detailed discussion of this talk is given at molcyt.org while references to our work in the general areas I am talking about at http://www.molcyt.com, under Publications. Please watch in HD high definition if your internet connection allows. The presentation can be viewed or downloaded from Slideshare (hyper-links to publications); all my content is CC-BY-NC so please feel free to use in your non-commercial presentations and outputs with acknowledgement. We all know that climate is climate change and its mitigation are critical Some of the challenges are summed up in the top photograph from south of Addis Abbaba in the the Rift Valley of Ethiopia. Drought and unpredictable climate prevent crops timely establishment of crops, and the consequences are exacerbated by overgrazing and collection of trees for fuelwood, themselves consequences of population growth, and all leading to loss of ...From:Pat Heslop-HarrisonViews:2 1ratingsTime:20:54More inScience Technology

Link:
Molecular Cytogenetics, Superdomestication, Biodiversity and Crop Breeding - Video

LG Optimus One Multi Rom Ginger DX + Genetics Final
forum.xda-developers.comFrom:lgoptimusonegeeksViews:4 1ratingsTime:01:59More inPeople Blogs

See the rest here:
LG Optimus One Multi Rom Ginger DX + Genetics Final - Video

Grand Challenges Canada - Joint Session with Keystone Symposia - Genetics and Innate Immunity
Ottawa, Canada - December 13, 2012From:GCGHMeetingsViews:3 0ratingsTime:01:01:53More inPeople Blogs

More:
Grand Challenges Canada - Joint Session with Keystone Symposia - Genetics and Innate Immunity - Video

Orthodonic Diagnosis
561.732.8877 Jamie J. Alexander DDS, PA 2521 South Federal Hwy. Email: drj@boyntonbeachdentist.com Website: http://www.boyntonbeachdentist.com Malocclusion is the dental term for teeth that don #39;t fit together properly. Literally, malocclusion means "bad bite." Orthodeontis is the branch of dentistry that corrects malocclusions and brings your teeth into proper alignment. Some people are lucky and naturally have straight teeth. Others aren #39;t as lucky. The size of your teeth and how they fit into your jaw are inherited traits, and malocclusion can often affect several generations. Besides genetics, malocclusion can also be caused by: bull;Accidents or disease bull;A missing tooth, allowing the teeth around the open space to shift. bull;Habits, such as thumb sucking, which can put pressure on teeth There are many types of malocclusions. Your upper or lower jaw may be too far in or out. There may not be enough space in your mouth for your teeth to develop properly, leading to crowding. On the other hand, you might have too much space between your teeth, allowing them to shift, or your teeth may be in crossbite, which means that one or more of your upper teeth bite inside your lower teeth. A malocclusion that isn #39;t corrected can really affect your profile and appearance. Poorly aligned teeth can also contribute to tooth decay, bone destruction, loss of teeth, and jaw joint problems. These may in turn cause headaches, difficulty in opening and closing your mouth, clicking and popping sounds, and ...From:Jamie Alexander DDS, PAViews:0 0ratingsTime:01:24More inHowto Style

The rest is here:
Orthodonic Diagnosis - Video

CANCER UPDATE: CAUSES, TREATMENT AND PREVENTION (Accessible Preview)
Surveys the fundamentals of how cancers develop, how they are treated, the role of genetics, and the role of lifestyle choices in cancer prevention. Meet three real people coping with different kinds of cancers and see how their lives are affected. Emphasizes that promising new treatments are being developed, but also that there is still much that needs to be learned. Engaging original animation clearly illustrates the process of how normal cells turn into cancer cells, how tumors develop, and how cancer cells metastasize to other parts of the body. Also presents the importance of early cancer screening and steps that take to reduce the risk of developing cancer. Producer/Distributor: HUMAN RELATIONS MEDIA Production Year: 2012 Grade Level: 7-12 Registered DCMP members can access this title for free at the following URL: http://www.dcmp.orgFrom:dcmpnadViews:0 0ratingsTime:04:09More inEducation

Continued here:
CANCER UPDATE: CAUSES, TREATMENT AND PREVENTION (Accessible Preview) - Video

Quivira Coalition Conference, Dr. Molly Jahn - Seeds, 2012
Quivira Coalition Conference, produced by LivingWebFilms.com - This year #39;s 11th Quivira Coalition Conference in Albuquerque, NM on Nov 14th, 2012 was focused on How to Feed Nine Billion People From the Ground Up: Soil, Seeds, Water, Plants, Livestock, Forests, Organics, and People. In this conference, Quivira Coalition explored a variety of innovative practices that are already successfully intensifying food production while preserving, maintaining, and restoring the natural world. Speakers shared their hands-on experience and ideas for feeding all life - from the ground up. Quivira Coalition Conference, Dr. Molly Jahn - Seeds, 2012 Special Advisor to the Chancellor and Provost for Sustainability Sciences and Professor of Agronomy and Genetics, Nelson Institute for Environmental Studies, Center for Sustainability and the Global Environment, University of Wisconsin-Madison.From:QuiviraCoalitionViews:7 0ratingsTime:46:12More inEducation

Go here to read the rest:
Quivira Coalition Conference, Dr. Molly Jahn - Seeds, 2012 - Video

Trade Secrets Revealed: STOCK MARKET GHOST (The Hidden)
xrl.us Trade the Forex like A pro, learn how to sell currency of one country to buy that of another and profit. Top insider Forex trading strategies revealed. "These days, forex trading has become one of the most popular trading places where you can earn money. It involves in dealing with the people from all over the world, which is why you can have a higher chance of making money according to your preference. However, in the past few years, the trading has seen several crashes because of the economy. Nevertheless, people can still have the best chance to generate income once they have take advantage of the forex market.Also, when it comes to futures trading, you have to make sure that you will take advantage it. Listed here are the reasons why the forex market continues to be popular for everyone who want to push their luck and optimize their earnings.Here are the reasons that you need to know about the type of trading and why it has become one of the best promising ways to generate money: Accuracy and accessibility - You should know that once you have done trading regarding the forex market, you can have accuracy in trading and ease. Traders have the freedom to follow their trading everyday without having any problems. They can even do trading at any time of the day ..." #9658; #9658; #9658; Enjoy the video? Subscribe! #9668; #9668; #9668; Download Here: What is The Hidden? In the early 1950s human genetics experimentation was taking its first, tentative steps. Amongst many other black projects, a ...From:TopForexSecretsViews:0 0ratingsTime:03:11More inHowto Style

See the article here:
Trade Secrets Revealed: STOCK MARKET GHOST (The Hidden) - Video

Giant Panda Genome Reveals Human Toll on Species
The genomic history of the giant panda has been uncovered, revealing evidence of their population history and local adaptation. The research team tracked the panda #39;s history back to its earliest days by carrying out whole genome resequencing of 34 wild giant pandas. They found that for millions of years, global changes in climate were the main driver for panda population fluctuation until recently, when human activities likely caused population divergence and serious decline. The giant panda is now the rarest bear in the world. The hope is that the study, published in Nature Genetics, could address conservation methods not just for giant pandas but other endangered species as well.From:slatesterViews:93 7ratingsTime:00:46More inNews Politics

See original here:
Giant Panda Genome Reveals Human Toll on Species - Video